Based on the empirical evidence we have ASML succeeded in spite of the EU not because of it (so “they” is bot exactly fair). There is not much EU has going on besides that when it comes to growth and innovation.

It’s a bit like Novo Nordisk, they had a huge win and then just focused on making as much money while it lasted while more innovative companies ate up their market.